These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19494648)

  • 21. Ocriplasmin for pharmacologic vitreolysis.
    Kuppermann BD
    Retina; 2012 Sep; 32 Suppl 2():S225-8; discussion S228-31. PubMed ID: 22929326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacovitrectomy.
    Dolz-Marco R; Gallego-Pinazo R; Díaz-Llopis M; Arévalo JF
    Dev Ophthalmol; 2014; 54():126-34. PubMed ID: 25196761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacologic Vitreolysis in Vascular Diseases of the Retina.
    Soliman MK; Agarwal A; Sarwar S; Hanout M; Sadiq MA; Do DV; Nguyen QD
    Ophthalmic Surg Lasers Imaging Retina; 2016 Jan; 47(1):60-8. PubMed ID: 26731211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacologic vitreolysis.
    Sebag J
    Retina; 1998; 18(1):1-3. PubMed ID: 9502274
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of intravitreal hyaluronidase on the clearance of tritiated water from the vitreous to the choroid.
    Foulds WS; Allan D; Moseley H; Kyle PM
    Br J Ophthalmol; 1985 Jul; 69(7):529-32. PubMed ID: 4016049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic vitreolysis with ocriplasmin: rationale for use and therapeutic potential in vitreo-retinal disorders.
    Khoshnevis M; Sebag J
    BioDrugs; 2015 Apr; 29(2):103-12. PubMed ID: 25812991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacologic vitreodynamics and molecular flux.
    Goldenberg DT; Trese MT
    Dev Ophthalmol; 2009; 44():31-36. PubMed ID: 19494650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzyme-induced vitreolysis can alleviate the progression of diabetic retinopathy through the HIF-1α pathway.
    Li C; Chen P; Zhang J; Zhang L; Huang X; Yao Y; Che X; Fan X; Ge S; Wang Z
    Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4964-70. PubMed ID: 23847321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacologic vitreolysis: rationale, potential indications, and promising agents.
    Gandorfer A
    Retina; 2012 Sep; 32 Suppl 2():S221-4. PubMed ID: 22929325
    [No Abstract]   [Full Text] [Related]  

  • 30. From the analysis of pharmacologic vitreolysis to the comprehension of ocriplasmin safety.
    Morescalchi F; Gambicorti E; Duse S; Costagliola C; Semeraro F
    Expert Opin Drug Saf; 2016 Sep; 15(9):1267-78. PubMed ID: 27388220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased hyaluronan concentration during primary rhegmatogenous retinal detachment.
    Kaprinis K; Symeonidis C; Papakonstantinou E; Tsinopoulos I; Dimitrakos SA
    Eur J Ophthalmol; 2016 Nov; 26(6):633-638. PubMed ID: 27198637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term effect of plasmin on the vitreolysis in rabbit eyes.
    Kim NJ; Yu HG; Yu YS; Chung H
    Korean J Ophthalmol; 2004 Jun; 18(1):35-40. PubMed ID: 15255235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Intravitreal autologous plasmin without associated-vitrectomy. Pharmacological vitreolysis, a perfeccionated method using urokinase].
    Díaz-Llopis M; Udaondo P; Salom D; García-Delpech S; Romero FJ
    Arch Soc Esp Oftalmol; 2008 May; 83(5):291-2. PubMed ID: 18464177
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pharmacological vitreolysis].
    Gandorfer A
    Klin Monbl Augenheilkd; 2011 Mar; 228(3):201-7. PubMed ID: 20845257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The safety of intravitreal hyaluronidase. A clinical and histologic study.
    Gottlieb JL; Antoszyk AN; Hatchell DL; Saloupis P
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2345-52. PubMed ID: 2242999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of hyaluronidase on the rate of diffusion in the vitreous body in vivo; experiments with radioactive phosphate on rabbit eyes.
    CRISTIANSSON J
    Acta Ophthalmol (Copenh); 1955; 33(5):571-82. PubMed ID: 13301639
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pharmacologic vitreolysis in diabetic rats].
    Luo M; Wang ZL; Shi WD; Fan XQ; Xu GT
    Zhonghua Yan Ke Za Zhi; 2009 May; 45(5):417-23. PubMed ID: 19576064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Delayed retinal changes following depolymerization of vitreous body by hyaluronidase].
    Szram S; Stankiewicz A; Kulig A
    Klin Oczna; 1975 Dec; 45(12):1233-6. PubMed ID: 1214434
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of biological stimuli on the viscosity of the vitreous.
    Kawano SI; Honda Y; Negi A
    Acta Ophthalmol (Copenh); 1982 Dec; 60(6):977-91. PubMed ID: 7170940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Electron microscopic investigations of vitreous collagen after treating the vitreous with liquefying substances (author's transl)].
    Schmut O; Roll P; Hofmann H
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1975 Aug; 196(2):187-97. PubMed ID: 169709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.